Anemia Drugs Market Top Companies, Business Growth & Investment Opportunities, Share, Segments and Forecast to 2030
Global Anemia Drugs Market – Overview
The Anemia
Drugs Market size is expected to grow at 8.9% CAGR, to reach USD 15,983.5
Million in the forecast period 2022-2030.
The global Anemia Drugs Market is growing with the sound
pace. According to a recent study report published by the Market Research
Future, the global anemia drugs market is booming and is expected to gain
prominence over the forecast period growing rapidly. The market is forecasted
to demonstrate a spectacular growth by 2022, surpassing its previous growth
records in terms of value with a sound CAGR during the anticipated period.
Anemia is characterized by weakness, shortness of breath and
a general tiredness due to a decrease in the total amount of red blood cells
(RBCs) or haemoglobin in the blood. The lowered haemoglobin results in a
lowered ability of the blood to carry oxygen. There are three main types of
anaemia, i.e. due to blood loss, due to decreased or faulty red blood cell
production and due to increased red blood cell breakdown. Anaemia affects a
quarter of people of the world and of the different types of anaemia iron deficiency
anaemia comprises of the largest number of people affected, about 1 billion
and resulting in approximately 215,000 deaths each year. Anaemia is also more
common in females than males. It also has a greater propensity to affect
children, pregnant and lactating women and the elderly. Factors such as growing
geriatric population, increasing awareness, rising focus on women health and,
rising prevalence of cancer, poor nutritional habits, rise in lactating and
pregnant women in developing regions, intestinal infections etc. are the major
drivers for the market growth during the forecast period. However, poor
absorption of intravenous iron drugs and the side effects associated with the
treatment are the restraining factors for the growth of the market during the
forecast period.
Market Segmentation:
Global anemia drugs market has been segmented
·
on the basis of anemia type which
comprises iron deficiency anemia, sickle cell anemia, aplastic anemia,
hemolytic anemia pernicious anemia and others.
·
On the basis of route of administration;
market is segmented into oral and injectable. On the basis of product type;
market is segmented into biologics and non-biologics.
·
On the basis of end users; market is
segmented into hospitals, self-administered and others.
Global Anemia Drugs Market:
The Global anemia drugs market has been evaluated as a
growing market and it is expected that the market will touch high growth
figures in future. The global anemia drugs market is expected to grow with CAGR
of ~8.4% during the forecast period. The rise will be led by the developing
regions and market development will represent a good strategy. Market
penetration is comparatively easy and the market is also devoid of a very
efficacious drug. Thus research and development collaboration between companies
will be a smart strategy. The rising healthcare funding in developing regions
also provide a good opportunity for further market development. Biologics
development pipeline represent another potential alternative for developing
anemia drugs.
Regional Analysis:
Depending on geographic region, Anemia Drugs market is
segmented into four key regions: America, Europe, Asia Pacific, and Middle East
& Africa. Globally, America is the largest market for anemia drugs closely
followed by Europe. Asia pacific region is however the fastest growing region
in anemia drugs market due to unmet medical needs, changing socio-economic
conditions, greater awareness towards women health etc.
Key Players:
The major participants of this Anemia
Drugs Market Players are: Amgen Inc., GlaxoSmithKline plc, Bluebird bio,
Biocon, GlycoMimetics Inc., Regen biopharma Inc., Bayer AG, Acceleron Pharma,
Eli Lilly and company and others.
Related Report-
https://bresdel.com/blogs/285040/Blood-Glucose-Test-Strips-Market-Analysis-in-depth-Detailed-Survey
https://www.linkedin.com/pulse/overt-hepatic-encephalopathy-market-size-share-top-vendors-gupta
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment